Rachel Beekman, PGY4 has had an incredibly productive year with several publications, a few of which are mentioned below:
Beekman R, Greer D, Brooks D, Maciel C. Clinical Reasoning: Prognostication after cardiac arrest: What do we really know? Neurology Resident and Fellow Section. Neurology, November 14, 2017; 89; 239-e244.
Hehir MK, Hobson-Webb LD, Benatar M, Barnett C, Silvestri NJ, Howard JF Jr, Howard D, Visser A, Crum BA, Nowak R, Beekman R, et al. Rituximab as treatment for anti-MUSK myasthenia gravis: Multicenter blinded prospective review. Neurology 2017;89:1069-1077.
*This study provides Class IV evidence that for patients with anti-MuSK MG, rituximab increased the probability of a favorable outcome.
Rachel Beekman, David M. Greer, Carolina B. Maciel. Poor neurologic outcomes after cardiac arrest: a spectrum with individual implications.. Epilepsy and Behavior Case Reports 2017;8:85-6.
Rachel Beekman, MD, Jessica M. Hu, MD, Steven I. Aronin, MD, Marican F. Malinis, MD. Diagnosing Ring-Enhancing Lesions in the Brain of a Patient With AIDS Without Brain Biopsy: A Case of Central Nervous System Histoplasmoma. Neurohospitalist 2017.
Rachel will be doing a Neurocritical Care Fellowship here at Yale next year, and we are so lucky she will be staying with us. Congrats, Rachel!
